Fore Biotherapeutics
A precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics
46 employees · est. 2011 · Philadelphia, United States
Viracta Therapeutics, Inc.
A precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients
31 employees · est. 2007 · United States
Viracta Therapeutics, Inc. is the older company (2011 vs 2007).
Side-by-Side Comparison
| Metric | Fore Biotherapeutics | Viracta Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2011 | 2007 older |
| Headquarters | ||
| Headquarters | Philadelphia, United States | United States |
| Employees | ||
| Employees | 46 | 31 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series D | IPO |
| Total Funding | ||
| Total Funding | $166.50M | $143.40M |
| Funding Rounds | ||
| Funding Rounds | 9 | 5 |
| Services | ||
| Services | Not tracked yet | development of targeted cancer therapies |
| Target Customers | ||
| Target Customers | Not tracked yet | oncologists, cancer treatment centers, patients with cancer |
| Taxonomy | ||
| Taxonomy | Precision Oncology, Cancer Therapies, Functional Genomics, Science, Innovation, Precision Medicine, Oncology Research, Drug Development, Cancer Treatment, Precision Medicine Company | Precision Oncology, Virus-Associated Cancers, Nanatinostat, Antiviral Therapy, EBV-Positive Lymphoma, Inducible Synthetic Lethality, Nasopharyngeal Carcinoma, Gastric Carcinoma, Epstein-Barr Virus, Lymphoproliferative Disorders, Immuno-Oncology, Phase 2 Clinical Trial, Oral Combination Therapy, Virus-Related Cancers, Valganciclovir |
| Website | ||
| Website | fore.bio | viracta.com |
About Fore Biotherapeutics
Fore Biotherapeutics is a biotechnology startup based in the United States, founded in 2011. The company's slogan, "A precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics," reflects its dedication to developing cancer therapies guided...
About Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc., founded in 2007, is a cutting-edge company within the biopharma and biotechnology sectors, headquartered in the United States. As a precision oncology entity, it focuses on tackling virus-associated cancers, striving to enhance patient outcomes globally. The company's ap...
We will tell you when either one moves
BounceWatch watches Fore Biotherapeutics and Viracta Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Fore Biotherapeutics and Viracta Therapeutics,... — by email.
Frequently Asked Questions
Compare Fore Biotherapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Fore Biotherapeutics on 11 Sep 2024, and Viracta Therapeutics, Inc. on 26 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
